Mammography Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Mammography Equipment Pipeline Market Report Overview

Mammography equipment is a type of medical imaging equipment that uses X-rays to capture images (mammograms) of the internal structures of the breasts. Mammography plays a key role in early diagnosis of breast cancer.

The mammography equipment pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       United States

·       Europe

·       Canada

·       China

·       Others

Key Segments ·       Breast Tomosynthesis Equipment

·       Full Field Digital Mammography Equipment

·       2D Digital Mammography Equipment

Key Regulatory Paths ·       510(k)

·       CE

·       MDL

·       NMPA

·       PMA

Leading Companies ·       Agfa HealthCare NV

·       Bionirs

·       Canon USA Inc

·       CapeRay Medical Pty Ltd

·       Cooper Union for the Advancement of Science and Art

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Mammography Equipment Pipeline Market Segmentation by Territories

A few of the key territories for mammography equipment pipeline products are the US, Europe, Canada, and China among others. As of June 2024, the US accounts for the highest number of mammography equipment pipeline products.

Mammography Equipment Pipeline Market Analysis by Territories, 2024 (%)

Mammography Equipment Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Mammography Equipment Pipeline Market

Download a Free Report Sample

Mammography Equipment Pipeline Market – Key Segments

A few of the key segments in the mammography equipment pipeline market are breast tomosynthesis equipment, full field digital mammography equipment, and 2D digital mammography equipment. As of June 2024, both breast tomosynthesis equipment and full field digital mammography segments have an equal number of pipeline products.

Mammography Equipment Pipeline Market Analysis by Segments, 2024 (%)

Mammography Equipment Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Mammography Equipment Pipeline Market

Download a Free Report Sample

Mammography Equipment Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths followed by the mammography equipment pipeline market are 510(k), CE, MDL, NMPA, and PMA. As of June 2024, 510(K) is the most followed pathway for pipeline products in the market.

Mammography Equipment Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Mammography Equipment Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Mammography Equipment Pipeline Market

Download a Free Report Sample

Mammography Equipment Pipeline Market – Competitive Landscape

A few of the key companies associated with the mammography equipment pipeline market are Agfa HealthCare NV, Bionirs, Canon USA Inc, CapeRay Medical Pty Ltd, and Cooper Union for the Advancement of Science and Art among others.

Agfa HealthCare NV: It is a healthcare information technology company that provides eHealth and digital imaging solutions. The company operates through diagnostic imaging, enterprise imaging, integrated care, and healthcare IT divisions offering products and services in the areas of cardiology, radiology, image processing, dermatology, nuclear medicine, clinical specialties, and veterinary care.

Mammography Equipment Pipeline Market Analysis by Companies, 2024

Mammography Equipment Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Mammography Equipment Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Mammography Equipment Pipeline Market Territories Outlook

  • United States
  • Europe
  • Global
  • Canada
  • China

Mammography Equipment Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • MDL
  • NMPA
  • PMA

Scope

This report provides:

  • Extensive coverage of the mammography equipment under development.
  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of mammography equipment and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of mammography equipment under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Agfa HealthCare NV
Bionirs
Canon USA Inc
CapeRay Medical Pty Ltd
Cooper Union for the Advancement of Science and Art
Fischer Imaging Corp
Florida International University
FMI Medical Systems Inc
GE Global Research
GE HealthCare Technologies Inc
Health Discovery Corp
iCAD Inc
Imagine Scientific Inc
Imaging Diagnostic Systems, Inc.
Lawrence Livermore National Laboratory
Micrima Ltd.
Microwave Vision SA
NovaScan Inc
PETsys Electronics SA
Philips Healthcare Informatics Inc
Real Time Tomography LLC
The University of Manchester
TomoWave Laboratories Inc
University at Buffalo
University College London
University of Canterbury
University of Chicago
University of Michigan
University of South Florida
Weinberg Medical Physics LLC
XLV Diagnostics, Inc.

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 9

2 Introduction 10

2.1 Mammography Equipment Overview 10

3 Products under Development 11

3.1 Mammography Equipment – Pipeline Products by Stage of Development 11

3.2 Mammography Equipment – Pipeline Products by Segment 12

3.3 Mammography Equipment – Pipeline Products by Territory 13

3.4 Mammography Equipment – Pipeline Products by Regulatory Path 14

3.5 Mammography Equipment – Pipeline Products by Estimated Approval Date 15

3.6 Mammography Equipment – Ongoing Clinical Trials 16

4 Mammography Equipment – Pipeline Products under Development by Companies 17

4.1 Mammography Equipment Companies – Pipeline Products by Stage of Development 17

4.2 Mammography Equipment – Pipeline Products by Stage of Development 19

5 Mammography Equipment Companies and Product Overview 20

5.1 Agfa HealthCare NV Company Overview 20

5.1.1 Agfa HealthCare NV Pipeline Products & Ongoing Clinical Trials Overview 20

5.2 Bionirs Company Overview 21

5.2.1 Bionirs Pipeline Products & Ongoing Clinical Trials Overview 21

5.3 Canon USA Inc Company Overview 22

5.3.1 Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview 22

5.4 CapeRay Medical Pty Ltd Company Overview 23

5.4.1 CapeRay Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

5.5 Cooper Union for the Advancement of Science and Art Company Overview 26

5.5.1 Cooper Union for the Advancement of Science and Art Pipeline Products & Ongoing Clinical Trials Overview 26

5.6 Fischer Imaging Corp Company Overview 27

5.6.1 Fischer Imaging Corp Pipeline Products & Ongoing Clinical Trials Overview 27

5.7 Florida International University Company Overview 30

5.7.1 Florida International University Pipeline Products & Ongoing Clinical Trials Overview 30

5.8 FMI Medical Systems Inc Company Overview 31

5.8.1 FMI Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 31

5.9 GE Global Research Company Overview 32

5.9.1 GE Global Research Pipeline Products & Ongoing Clinical Trials Overview 32

5.10 GE HealthCare Technologies Inc Company Overview 33

5.10.1 GE HealthCare Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 33

5.11 Health Discovery Corp Company Overview 34

5.11.1 Health Discovery Corp Pipeline Products & Ongoing Clinical Trials Overview 34

5.12 iCAD Inc Company Overview 35

5.12.1 iCAD Inc Pipeline Products & Ongoing Clinical Trials Overview 35

5.13 Imagine Scientific Inc Company Overview 36

5.13.1 Imagine Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.14 Imaging Diagnostic Systems, Inc. Company Overview 37

5.14.1 Imaging Diagnostic Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37

5.15 Lawrence Livermore National Laboratory Company Overview 39

5.15.1 Lawrence Livermore National Laboratory Pipeline Products & Ongoing Clinical Trials Overview 39

5.16 Micrima Ltd. Company Overview 40

5.16.1 Micrima Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40

5.17 Microwave Vision SA Company Overview 41

5.17.1 Microwave Vision SA Pipeline Products & Ongoing Clinical Trials Overview 41

5.18 NovaScan Inc Company Overview 44

5.18.1 NovaScan Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.19 PETsys Electronics SA Company Overview 45

5.19.1 PETsys Electronics SA Pipeline Products & Ongoing Clinical Trials Overview 45

5.20 Philips Healthcare Informatics Inc Company Overview 46

5.20.1 Philips Healthcare Informatics Inc Pipeline Products & Ongoing Clinical Trials Overview 46

5.21 Real Time Tomography LLC Company Overview 48

5.21.1 Real Time Tomography LLC Pipeline Products & Ongoing Clinical Trials Overview 48

5.22 The University of Manchester Company Overview 49

5.22.1 The University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 49

5.23 TomoWave Laboratories Inc Company Overview 50

5.23.1 TomoWave Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 50

5.24 University at Buffalo Company Overview 51

5.24.1 University at Buffalo Pipeline Products & Ongoing Clinical Trials Overview 51

5.25 University College London Company Overview 52

5.25.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 52

5.26 University of Canterbury Company Overview 53

5.26.1 University of Canterbury Pipeline Products & Ongoing Clinical Trials Overview 53

5.27 University of Chicago Company Overview 54

5.27.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 54

5.28 University of Michigan Company Overview 55

5.28.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 55

5.29 University of South Florida Company Overview 56

5.29.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 56

5.30 Weinberg Medical Physics LLC Company Overview 57

5.30.1 Weinberg Medical Physics LLC Pipeline Products & Ongoing Clinical Trials Overview 57

5.31 XLV Diagnostics, Inc. Company Overview 58

5.31.1 XLV Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58

6 Mammography Equipment- Recent Developments 59

6.1 Jun 05, 2024: Oxford Instruments Announces Directorate Change 59

6.2 Jun 05, 2024: Oxford Instruments Announces Board and Committee Changes 59

6.3 May 22, 2024: Sectra: Invitation to Presentation of Year-end Report 2023/2024 59

6.4 May 09, 2024: Volpara Health Appoints Clarity Quest as Agency of Record 59

6.5 May 08, 2024: ContextVision Releases Q1 Interim Report 2024 60

6.6 May 07, 2024: Radnet’s Lenox Hill Radiology to Host Mother’s Day Mammogram Screening Parties in New York City 61

6.7 May 07, 2024: Siemens Healthineers on Track to Meet Fiscal Year 2024 Targets After Second Quarter 62

6.8 May 02, 2024: Hologic Announces Financial Results for Second Quarter of Fiscal 2024 63

6.9 Apr 29, 2024: Revvity Announces Financial Results for the First Quarter of 2024 65

6.10 Apr 26, 2024: Hitachi Announces Consolidated Financial Results for Fiscal 2023 66

6.11 Apr 25, 2024: Carestream Announces Third Round of Layoffs 67

6.12 Apr 18, 2024: Memorial and Solis Mammography Open New Community-Based Breast Imaging Centers in Weston, Plantation and Hialeah 67

6.13 Apr 12, 2024: GE Healthcare to Feature Mobile Mammography Screening Truck along with Latest AI Platform as Part of SBI2024 Breast Cancer Imaging Showcase 68

6.14 Apr 12, 2024: ContextVision Releases Annual Report for Fiscal Year 2023 69

6.15 Apr 04, 2024: Siemens Healthineers Receives FDA 510(k) Clearance for MAMMOMAT B.brilliant Mammography System 69

6.16 Mar 18, 2024: Siemens Healthineers Intends to Close Fast Track Diagnostics 70

6.17 Mar 14, 2024: GE HealthCare and Hartford HealthCare Renew and Evolve 7-Year Collaboration to Advance Patient Care and Access in Connecticut 70

6.18 Mar 08, 2024: Sectra’s Nine-Month Interim Report 2023/2024 71

6.19 Mar 07, 2024: Introduction of Breast Imaging Legislation will Benefit Thousands of Kansans 72

6.20 Feb 28, 2024: New Technology Aiming to Improve Patients’ Outcomes in Breast Cancer 73

6.21 Feb 28, 2024: Philips Taps Stryker Controller as Next CFO 74

6.22 Feb 27, 2024: iCAD Expands Board of Directors With the Appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.c) 74

6.23 Feb 21, 2024: Sectra Announces Invitation to Presentation of Nine-month Interim Report 2023/2024 75

6.24 Feb 20, 2024: Philips Delivers Strong ESG Performance in 2023 75

6.25 Feb 14, 2024: GE HealthCare Management to Present at Upcoming Investor Conferences 77

6.26 Feb 13, 2024: Siemens Announces a 22% Increase in Revenue at 14% Pbt (As A % Of Revenue) In Q1 Fy 2024 Results 77

6.27 Feb 09, 2024: RSNA: Novel Technique has Potential to Transform Breast Cancer Detection 77

6.28 Feb 08, 2024: Siemens Announces Successful Start to Fiscal 2024 78

6.29 Feb 08, 2024: Banner Imaging Transforms Mammogram Experience With Innovative Approach 80

6.30 Feb 06, 2024: INSERTING and REPLACING GE HealthCare Reports Fourth Quarter and Full Year 2023 Financial Results 80

6.31 Jan 25, 2024: Revvity Elects Sophie Vandebroek and Michael Klobuchar to its Board of Directors 85

6.32 Jan 18, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2023 Results on February 6, 2024 86

6.33 Jan 12, 2024: Introduction of Breast Imaging Legislation Will Benefit Thousands of Pennsylvanians 86

6.34 Jan 04, 2024: Hologic to Announce Financial Results for the First Quarter of Fiscal 2024 on Thursday, February 1, 2024 87

6.35 Dec 20, 2023: Volpara Health Breast Density and Mammography Quality Software Highlighted in New Peer-Reviewed Research 87

6.36 Dec 15, 2023: Sectra’s Six-Month Interim Report 2023/2024: Strong Performance in All Operating Areas 88

6.37 Dec 12, 2023: Contract for NHS Scotland diagnostic imaging technology awarded to Sectra 89

6.38 Dec 05, 2023: Siemens Healthineers Appoints Vivek Kanade as New Head For Its Middle East and Africa Operations 90

6.39 Dec 05, 2023: RadNet Launches a Pilot Inside Walmart of its New MammogramNow Offering 90

6.40 Nov 27, 2023: Siemens Appoints Hakan Ozdemir as CEO of Smart Infrastructure in the Middle East 91

6.41 Nov 22, 2023: Oxford Instruments Brings Hill & Smith CFO Hannah Nichols to Board 91

6.42 Nov 22, 2023: Oxford Instruments Names Hill & Smith CFO to Its Board 91

6.43 Nov 22, 2023: Oxford Instruments Announces Appointment of Independent Non-Executive Director 91

6.44 Nov 16, 2023: Solis Mammography Sets the Stage for RSNA 2023 with Cutting-Edge Collaborations 92

6.45 Nov 14, 2023: Oxford Instruments Reports Interim Results for the Six Months to 30 September 2023 92

6.46 Nov 09, 2023: Solis Mammography and St. David’s HealthCare Announce Partnership to Expand Access to Women’s Breast Health Services in Central Texas 94

6.47 Oct 31, 2023: GE HealthCare Reports Third Quarter 2023 Financial Results 95

6.48 Oct 30, 2023: Revvity Announces Financial Results for the Third Quarter of 2023 96

6.49 Oct 26, 2023: ContextVision Reports Q3 Results 98

6.50 Oct 09, 2023: Revvity To Hold Earnings Call on Monday, October 30, 2023 98

6.51 Oct 02, 2023: Oxford Instruments Welcomes New Chief Executive, Richard Tyson 98

6.52 Sep 27, 2023: Mercy Health’s New Mobile Mammography Coaches Hit The Road 99

6.53 Sep 21, 2023: Hologic and Bayer Announce International Partnership to Deliver Comprehensive Contrast-Enhanced Mammography Package to Breast Imaging Facilities 100

6.54 Sep 18, 2023: Hitachi Vantara Appoints New GM for Sub-Saharan Africa 100

6.55 Sep 13, 2023: Davita Launches Community Health Tour to Provide Free Kidney Screenings and Education Coast-To-Coast 100

6.56 Sep 12, 2023: Hitachi Makes Executive Responsibility Change 101

6.57 Sep 07, 2023: Philips Reaches Resolution of US Economic Loss Litigation 101

6.58 Sep 05, 2023: Siemens Healthineers Expands Production Site in Rudolstadt, Germany and Creates New Jobs 102

6.59 Aug 29, 2023: Carolina Breast Imaging Specialists, PLLC Is First in Nation to Adopt Groundbreaking Imagio Breast Imaging System for Breast Cancer Diagnosis 102

6.60 Aug 28, 2023: ContextVision Appoints Richard Hallstrom as Chief Financial Officer 103

6.61 Aug 24, 2023: Shenzhen Beacon Display Technology Receives 510(k) Clearance for 12MP Color LCD Monitor C1216W 103

6.62 Aug 24, 2023: ContextVision Announces Strong Second Quarter With Solid Margin Growth 103

6.63 Aug 23, 2023: Sectra Announces Invitation to Presentation for Three-Month Interim Report 2023/2024 104

6.64 Aug 14, 2023: iCAD and Google Health Expand Integration of Google’s AI Technology with iCAD’s ProFound Breast Health Suite for 2D Mammography for Use as Independent Reader 105

6.65 Aug 07, 2023: Notice of Annual General Meeting in Sectra AB (publ) 106

6.66 Jul 28, 2023: CoxHealth and Philips partner on virtual care solution 107

6.67 Jul 27, 2023: ConcertAI’s TeraRecon Partners with ClariPi to Integrate AI Solutions for Comprehensive Medical Imaging on Eureka Clinical AI Platform 108

6.68 Jul 12, 2023: Revvity to Hold Earnings Call on Tuesday, August 1, 2023 108

7 Appendix 109

7.1 Methodology 109

7.2 About GlobalData 112

7.3 Contact Us 112

7.4 Disclaimer 112

Table

Mammography Equipment – Pipeline Products by Stage of Development 11

Mammography Equipment – Pipeline Products by Segment 12

Mammography Equipment – Pipeline Products by Territory 13

Mammography Equipment – Pipeline Products by Regulatory Path 14

Mammography Equipment – Pipeline Products by Estimated Approval Date 15

Mammography Equipment – Ongoing Clinical Trials 16

Mammography Equipment Companies – Pipeline Products by Stage of Development 17

Mammography Equipment – Pipeline Products by Stage of Development 19

Agfa HealthCare NV Pipeline Products & Ongoing Clinical Trials Overview 20

DR18M Mammography Detector – Product Status 20

DR18M Mammography Detector – Product Description 20

Bionirs Pipeline Products & Ongoing Clinical Trials Overview 21

MamoRef – Product Status 21

MamoRef – Product Description 21

Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview 22

Photoacoustic Mammography Device – Product Status 22

Photoacoustic Mammography Device – Product Description 22

CapeRay Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

Aceso – Product Status 23

Aceso – Product Description 23

Aegle – Product Status 24

Aegle – Product Description 24

PantoScanner Soteria – Product Status 24

PantoScanner Soteria – Product Description 25

Cooper Union for the Advancement of Science and Art Pipeline Products & Ongoing Clinical Trials Overview 26

At-Home Breast Cancer Screening System – Product Status 26

At-Home Breast Cancer Screening System – Product Description 26

Fischer Imaging Corp Pipeline Products & Ongoing Clinical Trials Overview 27

MammoCAT 2D System – Product Status 27

MammoCAT 2D System – Product Description 27

MammoCAT CT – Product Status 28

MammoCAT CT – Product Description 28

MammoCAT DBT – Product Status 28

MammoCAT DBT – Product Description 29

MammoCAT DM – Product Status 29

MammoCAT DM – Product Description 29

Florida International University Pipeline Products & Ongoing Clinical Trials Overview 30

Handheld Imager – Product Status 30

Handheld Imager – Product Description 30

FMI Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 31

ScintiStar Mammo LPX PET/CT – Product Status 31

ScintiStar Mammo LPX PET/CT – Product Description 31

GE Global Research Pipeline Products & Ongoing Clinical Trials Overview 32

PET-Mammogram-Biopsy System – Product Status 32

PET-Mammogram-Biopsy System – Product Description 32

GE HealthCare Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 33

Second Generation Tomosynthesis Unit – Product Status 33

Second Generation Tomosynthesis Unit – Product Description 33

Health Discovery Corp Pipeline Products & Ongoing Clinical Trials Overview 34

MammoSIGHT – Product Status 34

MammoSIGHT – Product Description 34

iCAD Inc Pipeline Products & Ongoing Clinical Trials Overview 35

Integrated Profound AI – 2D Mammography – Product Status 35

Integrated Profound AI – 2D Mammography – Product Description 35

Imagine Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 36

STARLIGHT – Product Status 36

STARLIGHT – Product Description 36

Imaging Diagnostic Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37

CTLM 3.0 Scanner – Product Status 37

CTLM 3.0 Scanner – Product Description 37

CTLM System – Product Status 38

CTLM System – Product Description 38

Lawrence Livermore National Laboratory Pipeline Products & Ongoing Clinical Trials Overview 39

Phase Sensitive X-Ray Imager – Product Status 39

Phase Sensitive X-Ray Imager – Product Description 39

Micrima Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40

Maria System – Next Version – Product Status 40

Maria System – Next Version – Product Description 40

Microwave Vision SA Pipeline Products & Ongoing Clinical Trials Overview 41

Wavelia Microwave Breast Imaging System – Product Status 41

Wavelia Microwave Breast Imaging System – Product Description 41

Microwave Vision SA – Ongoing Clinical Trials Overview 42

Wavelia Microwave Breast Imaging System – Open-label,Single Site,Pilot Clinical Investigation to Assess Detectability and Sizing of Invasive Breast Cancers,Detectability of Benign Breast Lesions,Differentiation Between Malignant and Benign Breast Lesions Using Wavelia # 2 43

NovaScan Inc Pipeline Products & Ongoing Clinical Trials Overview 44

Electrical Mammogram – Product Status 44

Electrical Mammogram – Product Description 44

PETsys Electronics SA Pipeline Products & Ongoing Clinical Trials Overview 45

Clear-PEM Sonic – Product Status 45

Clear-PEM Sonic – Product Description 45

Philips Healthcare Informatics Inc Pipeline Products & Ongoing Clinical Trials Overview 46

MicroDose 3D S90 – Product Status 46

MicroDose 3D S90 – Product Description 46

Positron Mammography Imaging Device – Product Status 47

Positron Mammography Imaging Device – Product Description 47

Real Time Tomography LLC Pipeline Products & Ongoing Clinical Trials Overview 48

Carbon Nanotube-Based Stationary Digital Breast Tomosynthesis System – Product Status 48

Carbon Nanotube-Based Stationary Digital Breast Tomosynthesis System – Product Description 48

The University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 49

Portable Breast Scanner – Product Status 49

Portable Breast Scanner – Product Description 49

TomoWave Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 50

LOUISA-3D Breast Imaging System – Product Status 50

LOUISA-3D Breast Imaging System – Product Description 50

University at Buffalo Pipeline Products & Ongoing Clinical Trials Overview 51

Dual Scan Mammoscope – Product Status 51

Dual Scan Mammoscope – Product Description 51

University College London Pipeline Products & Ongoing Clinical Trials Overview 52

X-Ray System – Breast Cancer – Product Status 52

X-Ray System – Breast Cancer – Product Description 52

University of Canterbury Pipeline Products & Ongoing Clinical Trials Overview 53

3D Digital Imaging System – Product Status 53

3D Digital Imaging System – Product Description 53

University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 54

Digital Specimen Tomosynthesis Imaging System – Product Status 54

Digital Specimen Tomosynthesis Imaging System – Product Description 54

University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 55

Computerized Detection System – Breast Cancer – Product Status 55

Computerized Detection System – Breast Cancer – Product Description 55

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 56

Computer-based System – Mammographic Calcifications Clusters – Product Status 56

Computer-based System – Mammographic Calcifications Clusters – Product Description 56

Weinberg Medical Physics LLC Pipeline Products & Ongoing Clinical Trials Overview 57

MRI-Compatible PEM Scanner – Product Status 57

MRI-Compatible PEM Scanner – Product Description 57

XLV Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58

Digital Mammography Machine 1824 – Product Status 58

Digital Mammography Machine 1824 – Product Description 58

Glossary 111

Figures

Mammography Equipment – Pipeline Products by Stage of Development 11

Mammography Equipment – Pipeline Products by Segment 12

Mammography Equipment – Pipeline Products by Territory 13

Mammography Equipment – Pipeline Products by Regulatory Path 14

Mammography Equipment – Pipeline Products by Estimated Approval Date 15

Mammography Equipment – Ongoing Clinical Trials 16

Frequently asked questions

Mammography Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Mammography Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Mammography Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Mammography Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.